PULMONX CORPORATION Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
PULMONX CORPORATION (LUNG) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 11.39 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-04
- PULMONX CORPORATION antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 11.90M shares, a 43.03% increase year-over-year.
- PULMONX CORPORATION antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 8.32M shares, a 20.30% increase year-over-year.
- PULMONX CORPORATION antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-03-31 was 6.91M shares, a 14.45% increase year-over-year.
- PULMONX CORPORATION antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2023-03-31 was 6.04M shares, a 50.62% increase year-over-year.
- PULMONX CORPORATION antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 9.89M shares, a 53.57% increase from fiscal 2024.
- PULMONX CORPORATION antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 6.44M shares, a 18.25% increase from fiscal 2023.
- PULMONX CORPORATION antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 5.44M shares, a 51.22% increase from fiscal 2022.
- PULMONX CORPORATION antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 3.60M shares, a 26.84% increase from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | 11.39M shares 10-Q · filed 2026-08-04 | ||||
| 2026-03-31 | 11.90M shares 10-Q · filed 2026-05-04 | ||||
| 2025-12-31 | 9.89M shares 10-K · filed 2026-03-10 | ||||
| 2025-09-30 | 7.80M shares 10-Q · filed 2025-11-12 | ||||
| 2025-06-30 | 8.11M shares 10-Q · filed 2026-08-04 | ||||
| 2025-03-31 | 8.32M shares 10-Q · filed 2026-05-04 | ||||
| 2024-12-31 | 6.44M shares 10-K · filed 2026-03-10 | ||||
| 2024-09-30 | 6.71M shares 10-Q · filed 2025-11-12 | ||||
| 2024-06-30 | 7.02M shares 10-Q · filed 2025-08-01 | ||||
| 2024-03-31 | 6.91M shares 10-Q · filed 2025-05-02 | ||||
| 2023-12-31 | 5.44M shares 10-K · filed 2025-02-25 | ||||
| 2023-09-30 | 5.60M shares 10-Q · filed 2024-11-01 | ||||
| 2023-06-30 | 5.83M shares 10-Q · filed 2024-08-02 | ||||
| 2023-03-31 | 6.04M shares 10-Q · filed 2024-05-03 | ||||
| 2022-12-31 | 3.60M shares 10-K · filed 2024-02-27 | ||||
| 2022-09-30 | 3.74M shares 10-Q · filed 2023-11-03 | ||||
| 2022-06-30 | 3.88M shares 10-Q · filed 2023-08-04 | ||||
| 2022-03-31 | 4.01M shares 10-Q · filed 2023-05-08 | ||||
| 2021-12-31 | 2.84M shares 10-K · filed 2023-03-01 | ||||
| 2021-09-30 | 2.96M shares 10-Q · filed 2022-11-08 | ||||
| 2021-06-30 | 3.22M shares 10-Q · filed 2022-08-08 | ||||
| 2021-03-31 | 3.08M shares 10-Q · filed 2022-05-09 | 3.16M shares 10-Q · filed 2021-05-12 | |||
| 2020-09-30 | 23.68M shares 10-Q · filed 2021-11-09 | ||||
| 2020-03-31 | 21.30M shares 10-Q · filed 2021-05-12 | ||||
| 2019-09-30 | 20.68M shares 10-Q · filed 2020-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |